Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 12Neoplasms 11Brain Neoplasms 10Lung Neoplasms 9Glioma 9Glioblastoma 9Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Recurrence 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neuroendocrine Tumors 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Dutasteride 2Blood Specimen Collection 2Urination 1Transurethral Resection of Prostate 1Therapeutics 1Radiotherapy 1Prostatectomy 1Prostate-Specific Antigen 1Magnetic Resonance Spectroscopy 1Adrenergic alpha-Antagonists 15-alpha Reductase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Prostatic Hyperplasia × Magnetic Resonance Spectroscopy × Clear all
NCT06116851 2023-11-03

PROMIC

Turku University Hospital

Recruiting
300 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡